A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

Protocol

NCT #: NCT06025578

Phase

3

Condition(s)

Idiopathic Pulmonary Fibrosis (IPF), Interstitial Lung Disease (ILD), Pulmonary Fibrosis (Including IPF)

Investigator

Gerard Criner, MD

Coordinator

Margaret Simko

Visit clinicaltrials.gov for full description.